Scenarios that move EYPT

EyePoint, Inc. - Common Stock

Scenarios that move EYPT: 2 analyses, 0 positive, 2 negative.

1. 2026-10-12 · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -31 · confidence medium · horizon weeks
2. 2026-09-29 · Kodiak Sciences shares soar 178% on positive wet AMD data — ▼ · impact -51 · confidence medium · horizon immediate

All scenarios · Run a scenario · Pricing